Evidence map›Paper›PMID 40770913›Full record

ReviewJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2026

Unravelling the genetic architecture of cerebral small vessel disease in the context of stroke.

Sathyaseelan Chakkarai, Quentin Le Grand, Lucas Wang Shaoxuan, Stephanie Debette, Muralidharan Sargurupremraj

Abstract readReview
In one paragraph

Review in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sathyaseelan ChakkaraiGlenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Sciences Center at San Antonio, San Antonio, Texas, USA.
Quentin Le GrandInstitut du Cerveau (ICM), Paris Brain Institute, INSERM U1127, UMR CNRS 7225 Paris, Sorbonne Université, Assistance Publique des Hôpitaux de Paris, Paris, France.ORCID 0000-0002-9299-0747
Lucas Wang ShaoxuanGlenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Sciences Center at San Antonio, San Antonio, Texas, USA.
Stephanie DebetteInstitut du Cerveau (ICM), Paris Brain Institute, INSERM U1127, UMR CNRS 7225 Paris, Sorbonne Université, Assistance Publique des Hôpitaux de Paris, Paris, France.
Muralidharan SargurupremrajGlenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Sciences Center at San Antonio, San Antonio, Texas, USA.ORCID 0000-0003-1684-3750

Funding

South Texas Alzheimer's Disease Research CenterP30AG066546 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Sudha Seshadri · 2021 to 2026
$24.0M
PRECURSORS OF STROKE INCIDENCE AND PROGNOSISR01NS017950 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Hugo Javier Aparicio, Jose Rafael Romero · 1985 to 2026
$22.9M
Plasma Proteome and Risk of Alzheimer Dementia and Related Endophenotypes in the Framingham StudyRF1AG063507 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GERSZTEN, ROBERT E, RAMACHANDRAN, VASAN S · 2019 to 2019
$4.2M
South Texas Medical Scientist Training Program (STX-MSTP)T32GM145432 · NIGMS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Jose E Cavazos, Ratna K Vadlamudi · 2023 to 2026
$2.3M
Computational Genomics Summer Institute and Mentoring NetworkR25GM135043 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ESKIN, ELEAZAR · 2020 to 2025
$1.6M
NIA NIH HHS P30 AG066546NIA NIH HHS RF1 AG063507NIGMS NIH HHS R25 GM135043NIGMS NIH HHS T32 GM145432NINDS NIH HHS R01 NS017950
6 · The paper itself

Abstract

Cerebral small vessel disease (cSVD) is a major contributor to stroke, dementia, and cognitive decline. Despite significant progress through large-scale genome-wide association studies (GWAS) for cSVD and stroke, the genetic architecture underlying these conditions remains poorly understood. This review highlights recent advancements in statistical tools and provides a comprehensive overview of current insights into the genetic underpinnings of cSVD and stroke. We focus on the relevance of non-additive effects, local heritability, and polygenicity in shaping these traits. While single nucleotide polymorphism (SNP)-based heritability estimates for stroke and cSVD traits remain lower than pedigree-based estimates, we explore challenges and opportunities in addressing this "missing heritability." In particular, we emphasize the importance of investigating both common and rare variants, to better characterize the genetic basis of cSVD. Furthermore, we discuss the role of negative selection in shaping complex disease traits and the relevance of the "omnigenic" model in the context of cSVD traits. In summary, we aim to provide a more nuanced understanding of cSVD and stroke genetics, paving the way for future research into their molecular mechanisms.

Indexed as

Cerebral Small Vessel DiseasesStrokeGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansPolymorphism, Single NucleotideCerebral small vessel diseaseGWASmissing heritabilityneuroimagingpolygenicity

Identifiers

PMID40770913
PMCPMC12331658

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.